Skip to Content

Join the 'Donepezil' group to help and get support from people like you.

Donepezil News

There's Still No Proven Way to Prevent Alzheimer's

Posted 19 Dec 2017 by Drugs.com

MONDAY, Dec. 18, 2017 – Medical science has failed to prove that any treatment, therapy or brain exercise can help prevent dementias such as Alzheimer's disease, an extensive new review has concluded. No medications, over-the-counter remedies or brain training programs have been proven in solid clinical trials to ward off dementia, researchers with the Minnesota Evidence-Based Practice Center in ...

A More Accurate Predictor for Alzheimer's?

Posted 29 Sep 2017 by Drugs.com

FRIDAY, Sept. 29, 2017 – A new test that checks for multiple gene variants linked with Alzheimer's disease may be more effective than testing for a single genetic variant, a new study suggests. The genetic variant APOE E4 is regarded as the strongest genetic predictor of whether a person is likely to develop the memory-robbing disease. But it's present in only 10 to 15 percent of people. And ...

Study: Gene Test Needed Before Using Alzheimer's Drug 'Off-Label'

Posted 8 Mar 2017 by Drugs.com

TUESDAY, March 7, 2017 – A drug used to treat Alzheimer's disease should not be prescribed to people with milder mental impairment without first giving them a genetic test, a new study urges. The drug is donepezil (brand name: Aricept). Donepezil could speed mental decline in someone with mild cognitive impairment who has a specific genetic variation, according to Sophie Sokolow, an associate ...

Dementia Meds May Lead to Harmful Weight Loss: Study

Posted 3 Aug 2015 by Drugs.com

MONDAY, Aug. 3, 2015 – A class of drugs widely used to treat dementia – called cholinesterase inhibitors – could cause harmful weight loss in some patients, a new study suggests. These medications include Aricept (donepezil), Razadyne (galantamine) and Exelon (rivastigmine). "Our study provides evidence in a large, real-world population that cholinesterase inhibitors may contribute to ...

Alzheimer's Drugs May Benefit Heart, Study Finds

Posted 5 Jun 2013 by Drugs.com

WEDNESDAY, June 5 – Drugs used to treat early-stage Alzheimer's disease may also reduce patients' risk of heart attack and death, according to a new study. Researchers followed more than 7,000 Alzheimer's disease patients in Sweden for more than three years. Those taking cholinesterase inhibitors had a 38 percent lower risk of heart attack, a 26 percent lower risk of death from cardiovascular ...

Study Produces Mixed Results on Alzheimer's Drugs

Posted 7 Mar 2012 by Drugs.com

WEDNESDAY, March 7 – A new study offers up mixed results about two medications used to treat the symptoms of the memory-robbing disease known as Alzheimer's. While patients didn't get a major mental boost when doctors added the drug Namenda to their regimen when they were already taking Aricept, they did find that continuing Aricept – a commonly prescribed drug for Alzheimer's in the United ...

Some People With Alzheimer's Take Conflicting Drugs

Posted 28 Oct 2011 by Drugs.com

FRIDAY, Oct. 28 – Many Alzheimer's patients who take cholinesterase inhibitors to slow their brain disease also take drugs that counter the effects of those Alzheimer's medications, a new study says. Clinical trials have shown that cholinesterase inhibitors such as Aricept (donepezil) have a modest impact on the functional and cognitive decline caused by Alzheimer's disease, noted the ...

Eisai Inc. and Pfizer Inc Announce U.S. FDA Approval for New Higher-Dose Aricept (donepezil HCl) 23 mg Tablet for the Treatment of Moderate-to-Severe Alzheimer's Disease

Posted 26 Jul 2010 by Drugs.com

WOODCLIFF LAKE, N.J. & NEW YORK--(BUSINESS WIRE)--Jul 24, 2010 - Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept (donepezil HCl) 23 mg tablet for the treatment of moderate-to-severe Alzheimer's disease (AD). Aricept 23 mg tablet offers another dosing option for patients with moderate-to-severe AD, for whom ...

FDA Approves Generic Aricept to Treat Dementia Related to Alzheimer's Disease

Posted 16 Dec 2009 by Drugs.com

ROCKVILLE, Md., Dec. 16, 2009-The U.S. Food and Drug Administration approved the first generic versions of Aricept (donepezil hydrochloride) orally disintegrating tablets on Dec. 11. Donepezil hydrochloride is indicated for the treatment of dementia related to Alzheimer's disease. Orally disintegrating tablets dissolve on the tongue, without having to be swallowed whole. This may make it easier ...

Ask a Question

Further Information

Related Condition Support Groups

Alzheimer's Disease, Mild Cognitive Impairment, Lewy Body Dementia

Related Drug Support Groups

Aricept, Aricept ODT

Donepezil Patient Information at Drugs.com